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Abstract 
Obesity is rapidly becoming an emerging disease in developing countries due to the increasing westernization of 
societies and change in the lifestyle. The etiology of obesity is said to be multifactorial, with a combination of genetic 
and environmental factors. Literature has been extensively reviewed to provide a broad overview of obesity. Data for this 
review were obtained from original articles, review articles and textbooks. Internet search engines were also employed. 
The years searched were from 1993 to 2008. Obesity, classified in terms of the body mass index and the waist–hip ratio, 
has several associated co-morbidities such as diabetes mellitus, hypertension, degenerative osteoarthritis and infertility. 
In Nigeria, there is limited information on obesity. A literature review on obesity is necessary to improve the knowledge 
about obesity in developing countries, its prevention and its management.
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Obesity is a non-communicable disease which is gaining 
increasing importance globally and is a rapidly emerging 
disease in the developed world. It is a chronic condition 
characterized by an accumulation of body fat.[1] Obesity is 
one of the most important preventable diseases in developed 
countries. The prevalence of the disease is increasing in both 
industrialized nations and in those undergoing alterations 
in diet and activity patterns as a consequence of adoption 
of the western culture.[2]
Etiopathogenesis of obesity
The origin of obesity is unclear, but it appears to be 
multifactorial and requires the continuous differentiation of 
new adipocytes throughout life.[3] This process of adipocyte 
differentiation from preadipocytes has been shown to be 
controlled by members of the peroxisome proliferator-
activated receptor (PPARγ). There is said to be a genetic 
basis for the development of obesity.[2,4] Polymorphisms 
in various genes controlling appetite, metabolism, and 
adipocytokine release, such as adiponectin, predispose 
to obesity. Some genetic conditions that feature obesity 
have been identified (such as Prader–Willi syndrome and 
melanocortin receptor mutations), but known single-locus 
mutations have been found in only about 7% of obese 
individuals.[5,6]
There may be other factors influencing the expression of 
genetic characteristics that induce weight gain or allow 
weight loss. Leptin is a protein hormone that is produced 
by adipocytes.[6] It regulates body weight, metabolism and 
reproductive function.[7] It seems to provide the brain with 
needed feedback concerned with the dynamic stability of 
body fat mass. A loss of body fat leads to a decrease in leptin, 
which in turn leads to a state of positive energy balance, 
that is, food intake exceeds energy expenditure.[8]
In obesity, there is excessive adipose tissue mass.[3] Obesity 
results when the body’s intake is greater than output over 
a period of time due to a sedentary lifestyle.[9] Thus, dietary 
factors and physical activity patterns play a strong role in 
obesity, and this is called exogenous obesity.[5] Obesity is 
positively associated with dietary factors such as increased 
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fat intake, low fiber consumption, increased hidden sugars 
in prepared foods, reduced amounts of unrefined sugars, 
and inadequate fruit and vegetable intake.[9] The daily 
eating pattern also seems to be associated with weight 
change, especially high calorie diet, which can be measured 
in several ways:[9] actual weighing of food through direct 
observation, 24-h our dietary recall using food models 
to estimate calories, and daily eating patterns. The most 
objective is the direct observation method. In the absence 
of the highly objective methods, the dietary eating pattern 
could be used to have a rough guide in a clinic setting, for 
rapid assessment of the patient’s diet.[10]
A physical activity pattern, such as a sedentary lifestyle, is 
also associated with weight change. The physical activity 
pattern has important influence on physiological regulation 
of body weight. Decreased physical activity plays an 
important role in obesity. In South West Nigeria, there is no 
exercise culture, especially among women. However, women 
are engaged in some physical activity such as walking long 
distances to hawk their wares, which are strenuous, and even 
at times deleterious to health. Other lifestyle factors which 
could cause obesity include insufficient sleep, endocrine 
disruptors–food substances which interfere with lipid 
metabolism, decreased variability in ambient temperature 
and decreased rates of smoking which suppress appetite. 
Increased use of medication that leads to weight gain such 
as steroids and some antidepressants may cause weight gain. 
Increased distribution of ethnic and age groups that tend 
to be heavier, pregnancy at a later age and intrauterine and 
intergenerational effects also contribute to the etiology of 
obesity.[5] Psychological factors as well as menopause also 
predispose to weight gain.[11] Endocrine problems such as 
Cushing’s disease and polycystic ovary disease may lead to 
obesity. Positive natural selection of people with a higher 
body mass index (BMI), assortative mating, and heavier 
people forming relationships with each other are other 
factors which have been implicated in the etiology of 
obesity. Other social determinants to obesity include the 
income differential, marital status, and BMI change in 
friends, siblings or spouse irrespective of geographical 
distance. [5] Childhood and adolescent obesity have also 
been identified as risk factors for obesity in adulthood.[12]
Cultural attitudes also influence obesity.[4] For example, in 
a part of Nigeria, pubescent daughters of the wealthy are 
sent to fattening huts before marriage.
Classification of obesity
Obesity can be classified into central or peripheral obesity. 
In central obesity, otherwise called “android” obesity, the 
distribution of fat is commonly on the upper part of the trunk 
(the chest and abdomen) and is more common in the males.[2] 
Android obesity is more clearly associated with disordered lipid 
and glucose metabolism and diseases like diabetes mellitus, 
gout, atherosclerosis, osteoarthritis, cardiovascular disease 
especially hypertension, and some cancers.[2,13] However, in 
the peripheral or “gynecoid” type of obesity, the distribution 
of fat is mainly on the hip and thighs and is more common 
in females.[2,14] Before the menopause, lipid assimilation is 
favored in the abdominal and femoral depots. However, after 
the menopause, these differences in fat metabolism between 
the abdominal and femoral sites disappear. The differences 
seen in the metabolism of fat suggest that female hormones 
are responsible before the menopause.[2]
There are various measures of obesity, and the BMI is a very 
useful and common one. It is a mathematical formula that 
is highly correlated with the body fat.[15] BMI is calculated 
as weight in kilograms divided by the square of the height in 
meters.[16] The BMI takes into account both frame size and 
body composition and is considered to provide a realistically 
achievable range of healthy weights and is a predictor of 
dangers associated with obesity.[2,17-24] A BMI less than 18.5 
kg/m2 is underweight. Normal BMI ranges between 18.5 
and 24.9 kg/m2. A BMI greater than or equal to 25 kg/m2 
is overweight. Obesity is defined as having a BMI of 30 kg/
m2 or more. There are three grades of obesity:[1] grade 1, 
which is a BMI equal to or greater than 30 kg\m2; grade II, 
which is moderate obesity with a BMI of 35–39.9 kg/m2; 
and grade III, which is extreme or morbid obesity, and the 
BMI is greater than or equal to 40 kg/m2.
Waist–hip ratio (WHR) is another means of knowing if 
a person is obese and is calculated by using the ratio of 
waist circumference to hip circumference.[16] Waist and 
hip measurements are simple and their expression as a ratio 
(WHR) makes it possible to do studies on a large number 
of obese individuals. Using this method of calculation of 
WHR, extreme gynecoid distribution has a WHR of about 
0.5, whilst WHR is 1.0 in the android type.[2,25-28] Another 
classification of WHR is 0.76–0.80 which is normal, 
0.81–0.86 which is moderate obesity, while above 0.86 is 
severe obesity.[16]
Prevention of obesity
Primary and secondary prevention should be emphasized in 
the prevention of obesity. The healthcare costs of obesity 
are considerable, especially when complicated by associated 
conditions such as diabetes mellitus, osteoarthritis,[18] 
hypertension, gall stone disease, post-menopausal breast 
cancer, and colon cancer.[29] Prevention of obesity is thus 
cost effective and should begin in early childhood by 
instilling healthy patterns of exercise and diet.[9]
It is important to begin prevention of obesity early because 
prevalence of childhood obesity is increasing throughout the 
world. In some developing countries, there is an increasing 
trend toward the western lifestyle such as adoption of 
the dietary pattern of eating “fast foods”, which are high 
in carbohydrate and fat. Within the United Kingdom, 
estimates of obesity range from 6% in preschool children to 
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17% by the age of 15 years. Schools provide an opportunity 
for preventing and treating obesity and can be employed 
for primary prevention through early detection of obesity. 
The use of health promotion, intended to influence dietary 
and physical activity behavior as a method of prevention of 
obesity, can also be employed.[30]
Co-morbidities of obesity
There are several medical consequences of obesity.[5,6,19,31] 
These co-morbidities affect various systems of the body. [32-36] 
Cardiovascular system complications seen in obesity include 
hypertension. It is known that there is an increase of 3 
mmHg and 2 mmHg in systolic and diastolic pressures, 
with every 10 kg rise in body weight.[15,25] Cerebrovascular 
disease, ischemic heart disease and congestive cardiac 
disease are also the cardiovascular complications of 
obesity.[37] Other complications include varicose veins and 
pulmonary embolism. There is a three times increased 
risk of premature death with obesity. [9] In the endocrine 
system, type 2 diabetes mellitus is a co-morbidity which is 
commoner in obese patients.[5,31] Obese patients are also 
prone to dyslipemia.[38] Obesity increases the incidence 
of and mortality rate in type 2 diabetics.[37,39] Obesity also 
leads to infertility, menstrual irregularities and polycystic 
ovarian syndrome (PCOS).[2] Respiratory complications 
also occur in obese people, which include obstructive sleep 
apnea, central sleep apnea, or a combination of the two.[40] 
Asthma and obesity hypoventilation syndrome could also 
occur in obese people.[5]
The renal and genitourinary system in obesity could be 
affected in several ways: urinary incontinence,[9] erectile 
dysfunction, chronic renal failure, prostate cancer and 
hypogonadism in males, breast,[25] cervical, ovarian and 
uterine cancer in females, and still birth.[31] Gastrointestinal 
system complications include gastroesophageal reflux 
disease (GERD), fatty liver disease, and hernia. Colorectal 
and gall bladder cancers can also develop.[25] Cholesterol 
supersaturation of the bile in obese individuals causes 
cholelithiasis.[25,35]
In the dermatological system, skin diseases such as 
intertrigo and cutaneous moniliasis increase.[28,38] Obese 
people may also have stretch marks, cellulitis and 
carbuncles. Complications in the musculoskeletal system 
include osteoarthritis,[41-43] immobility, low back pain, and 
hyperuricemia which predisposes to gout.[5]
The neurological system is affected by cerebrovascular 
disease and carpal tunnel syndrome.[5,37] There are also 
several psychological problems of obesity. Depression, 
low self-esteem,[2,9] body dysmorphic disorder and social 
stigmatization are some of these psychological problems 
faced by the obese individual. Obesity is a cause of significant 
mortality and morbidity and generates great social and 
financial costs.[44]
Management of obesity
It is important to emphasize to the individual that 
management of obesity is lifelong.[45] Health education and 
counseling have a remarkable role in encouraging adoption 
of lifestyle modifications. Health education should be offered 
to the individual about the etiology and treatment options 
for obesity. Referral may be necessary to other members 
of the multidisciplinary team, such as the physiotherapist, 
occupational therapist, the social worker, the dietician, and 
the clinical psychologist.[41]
Lifestyle modification
Lifestyle modification in the management of the patient 
as a whole focuses on dietary modification and exercise. 
Weight reduction can be done through dietary modification 
and exercise. Dietary modification follows satisfactory 
counseling and involves a 24-hour activity associated dietary 
recall. This recall includes detailed information about the 
meal schedule, and the quantity and quality of food intake. 
The dietary recall is a verbal report of food intake over the 
past 24 hours, or “yesterday”, and may help in nutritional 
intervention.[45] The role of the physician is to set reasonable 
weight loss goals. A realistic goal is a weight loss of 0.5–1 
kg per week. This weight loss is achievable using diets of 
1000–1500 kcal/day, which is known as low calorie diet. 
All obese people lose weight on a low energy intake.[38] The 
physician should aim for a BMI of 25 kg\m2 for the patient 
who wants to undergo dietary modification. After 6 months 
of therapy, the rate of weight loss on this regimen usually 
declines and then plateaus.[45] The second phase of weight 
loss therapy is the maintenance phase and this second stage 
should take priority. The physician also helps the patient 
select an appropriate weight loss program, and if simple 
diet sheets are not effective for dietary modification, the 
Family Physician refers the patient to a dietitian.[30,45] Very 
low calorie diets that are less than 800 kcal/day can be used 
to treat morbid obesity. Very low calorie diets, however, 
generally have a limited place in the management of obesity 
as the pattern of eating cannot be maintained and rebound 
weight gain is seen on stopping this type of diet.[45] Once a 
patient has lost weight, diet still needs to be monitored by 
the physician, and also by behavioral and group therapy. 
There is, however, little evidence to show that dietary 
advice by physicians is heeded.[9] Most influence on diet 
comes from national food policy, price of food, advertising, 
general education and cultural influences.[4,9]
Behavioral therapy is effective individually and in groups, 
when combined with low calorie diets.[45] Behavior change 
strategies involve techniques in stimulus control. The 
simplest form of behavior therapy involves advice to avoid 
situations that tempt overeating. Other forms of advice are 
keeping food out of sight or eating only at the table.[9,45] 
Practice eating management such as eating slowly is also 
included under behavior therapy. Behavior substitution can 
also be done, such as exercising instead of eating when angry. 
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Self-monitoring could be done by keeping food and exercise 
diaries and rewards can be given as a form of behavioral therapy. 
Prevention of relapse in obesity may require group therapy. 
Cognitive restructuring could also be included such as use of 
personal self-talk that focuses on progress rather than failure.[45]
Group activities such as weight watchers, who offer weekly 
meetings focused on nutrition, behavior modification and 
relapse prevention, can be joined. Exercise is also encouraged 
in these weight loss groups. There is a one-time registration 
fee for the weight watchers and a weekly fee, and when 
participant reaches goal weight, he or she becomes a lifetime 
member and may attend monthly meetings without charge 
as an incentive and encouragement to the new members.[9,45]
Exercise is an integral part in lifestyle modification of 
obesity. [9,46] Exercise is a useful treatment for many other 
conditions managed by physicians. Regular exercise reduces 
the risk of coronary heart disease, diabetes mellitus, obesity, 
colon cancer and osteoporosis.[45,46] In hypertension, exercise 
can result in a reduction of 10 mmHg in systolic and 8 
mmHg in diastolic blood pressure. In hypercholesterolemia, 
exercise causes high-density lipoproteins (HDL) to increase 
and low-density lipoproteins (LDL) to decrease, therefore 
reducing the risk of atheroma formation. Exercise also helps 
to reduce anxiety and the intensity of depression.[46]
Assessment of physical activity includes asking about regular 
exercise such as walking to work, to the market and whether 
in active employment. The Allied Dunbar National Fitness 
Survey Activity levels are graded from 0 to 5. It measures an 
activity of 20 min on each occasion in the previous 4 weeks: 
5 stands for greater than or equal to 12 occasions of vigorous 
activity; 4 stands for greater than or equal to 12 occasions 
of a mix of moderate and vigorous activity; 3 stands for 
greater than or equal to 12 occasions of moderate activity; 2 
stands for 5–11 occasions of a mix of vigorous and moderate 
activity; 1 stands for 1–2 occasions of a mix of moderate and 
vigorous activity; and 0 stands for no moderate or vigorous 
activity of greater than 20 min duration. The target physical 
activity level as per the age group is 5 for 16–34 years, 4 for 
35–54 years, and 3 for 55–74 years.[46]
Negotiating change in lifestyle is possible by encouraging 
sedentary people to increase their activity levels. As with all 
lifestyle interventions, the patients must want to change if 
they are to alter their lifestyle. If exercise levels are satisfactory, 
congratulate and inform the patient about the benefits of 
exercise. If the levels of exercise are unsatisfactory, encourage 
the patient to increase the physical activity and support the 
individual with health education leaflets. There is more success 
if exercise recommended is moderate, if the exercise does not 
require a special facility, and if the type of exercise can be 
incorporated into daily life routines such as walking to work. [46] 
Regular aerobic exercise also helps to reduce weight and 
improve health. The Family Physician should tailor advice to 
suit the individual and local facilities available. Light exercise, 
such as aerobics, is as effective as walking to some.[9] Swimming 
and cycling are recommended for obese women due to lack of 
weight bearing during the activity. Other adjuncts to lifestyle 
modification for obesity include drug therapy.
Drug therapy
Medications for treatment of obesity are formulated to 
reduce energy intake, increase energy output or decrease 
the absorption of nutrients.[46] There are several types of 
drugs that can be used in the management of obesity.[9,46] 
Methylcellulose, which works by decreasing absorption of 
nutrients, has been tried but found ineffective for treatment 
of obesity. Phenteramine, a catecholaminergic drug, is 
used as an appetite suppressant and is only licensed for a 
12-week use in patients with moderate to severe obesity. 
Phenteramine is, however, not recommended for the routine 
management of severe obesity.[9] Rapid weight relapse 
usually occurs after short-term use of an appetite suppressant 
and Phenteramine also carries the added risk of pulmonary 
hypertension, which is rare and insidious in onset.
Orlistat (Xenical) is a gastric and pancreas lipase inhibitor. 
Orlistat decreases fat absorption in the intestines. Patients 
taking this drug are also started on a medical action plan, 
which includes diet and exercise. Orlistat is expensive and is 
only used for motivated patients (those who have lost over 2.5 
kg in the previous month and have a body mass index over 30 
kg\m2).[9] Anti-depressants may also be needed as an adjunct 
therapy for obesity, as some of these obese patients may be 
depressed because of their weight and some may end up eating 
more to ease their depression.[45] However, it is to be noted 
that some of these anti-depressants, especially Amitryptiline, 
could cause increased appetite and worsen obesity.
Surgery
The physician should only consider referral for obesity as 
a last resort, if behavioral and dietary modification have 
failed and BMI is over 40 kg\m2. Wiring of the jaws together 
so that only liquid diet can be taken through a straw can 
be done as a surgical modality while managing morbid 
obesity.[2] Gastroplasty is the most common procedure done 
surgically for managing obesity in developed countries.[9] 
Mortality following gastroplasty is high.[9] Other surgical 
modalities for management of obesity are gastric bypass,[47] 
adjustable silicone gastric banding (ASGB), and vertical 
gastric banding (VGB).[35] Surgical excision of excess fat 
from various sites has also been advocated and tried, but 
usually fat reappears at other sites and the scars produced 
following the excision of fat may be uncosmetic.[20]
Follow-up
The patient should be followed-up on a regular basis to 
encourage compliance with lifestyle modification and other 
forms of treatment modalities for obesity. It is essential to 
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maintain the patient’s motivation throughout the course of 
therapy and even as a lifestyle change.[9] Ongoing follow-up 
has been shown to help sustain weight loss in obesity.
Conclusion
Obesity, like other emerging diseases requires more systematic 
investigation to establish facts on it in developing countries, 
especially in view of its increasing importance globally.
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